Best Stocks Under $3 | Low-Priced Stocks for $3 or Less

1. Ur Energy NYSEAMERICAN:URG

$1.34 -0.04 (-2.90%)

Closing price 09/10/2026 04:10 PM Eastern

Extended Trading

$1.36 +0.01 (+1.12%)

As of 07:00 AM Eastern

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization: $548.39 million
Consensus Rating: Buy
Consensus Price Target: $2.32 (+72.9% Upside)
Volume: 4.39 million shares
Average Volume: 4.95 million shares
Today's Range: $1.33
▼
$1.38

2. CuriosityStream NASDAQ:CURI

$2.71 +0.11 (+4.23%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$2.67 -0.04 (-1.55%)

As of 06:07 AM Eastern

CuriosityStream Inc operates as a factual content streaming service and media company. The company provides premium video and audio programming services in various categories of factual entertainment, including science, history, society, nature, lifestyle, and technology through direct subscription video on-demand (SVoD) platforms accessible by internet connected devices, or indirectly via distribution partners who deliver CuriosityStream content via distributor's platform or system, as well as through bundled content licenses for SVoD and linear offerings, talks and courses, and partner bulk sales. More about CuriosityStream

Market Capitalization: $154.28 million
P/E Ratio: 271.00
Consensus Rating: Buy
Consensus Price Target: $5.50 (+103.0% Upside)
Volume: 605,711 shares
Average Volume: 2.27 million shares

3. Nouveau Monde Graphite NYSE:NMG

$1.34 -0.03 (-2.48%)

Closing price 09/10/2026 03:58 PM Eastern

Extended Trading

$1.37 +0.03 (+2.25%)

As of 07:02 AM Eastern

Nouveau Monde Graphite Inc engages in the acquisition, exploration, development, and evaluation of mineral properties in Quebec, Canada. More about Nouveau Monde Graphite

Market Capitalization: $220.33 million
Consensus Rating: Buy
Consensus Price Target: $4.67 (+249.3% Upside)
Volume: 297,048 shares
Average Volume: 373,038 shares
Today's Range: $1.33
▼
$1.37

4. iBio NASDAQ:IBIO

$1.23 -0.04 (-2.78%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$1.25 +0.03 (+2.45%)

As of 07:00 AM Eastern

iBio, Inc, a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. More about iBio

Market Capitalization: $81.03 million
Consensus Rating: Buy
Consensus Price Target: $5.00 (+308.2% Upside)
Volume: 308,945 shares
Average Volume: 736,857 shares
Today's Range: $1.22
▼
$1.26

5. Galiano Gold NYSEAMERICAN:GAU

$2.16 -0.08 (-3.57%)

Closing price 09/10/2026 04:10 PM Eastern

Extended Trading

$2.17 +0.01 (+0.51%)

As of 07:00 AM Eastern

Galiano Gold Inc engages in the exploration and evaluation of gold properties in Canada. Its flagship asset is the Asanko Gold Mine that covers an area of approximately 21,000 hectares located in Ghana, West Africa. More about Galiano Gold

Market Capitalization: $585.82 million
P/E Ratio: 8.31
Consensus Rating: Buy
Consensus Price Target: $4.25 (+96.8% Upside)
Volume: 2.15 million shares
Average Volume: 2.66 million shares

6. Palisade Bio NASDAQ:PALI

$2.01 -0.04 (-1.95%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$2.05 +0.04 (+1.94%)

As of 07:01 AM Eastern

Palisade Bio, Inc, a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. More about Palisade Bio

Market Capitalization: $357.26 million
Consensus Rating: Buy
Consensus Price Target: $9.00 (+347.8% Upside)
Volume: 2.65 million shares
Average Volume: 1.64 million shares
Today's Range: $2.01
▼
$2.11

7. Inhibikase Therapeutics NASDAQ:IKT

$2.33 -0.08 (-3.32%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$2.34 +0.00 (+0.21%)

As of 09/10/2026 07:30 PM Eastern

Inhibikase Therapeutics, Inc, a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. More about Inhibikase Therapeutics

Market Capitalization: $336.28 million
Consensus Rating: Buy
Consensus Price Target: $5.40 (+131.8% Upside)
Volume: 332,368 shares
Average Volume: 376,901 shares
Today's Range: $2.32
▼
$2.39

8. Perspective Therapeutics NYSEAMERICAN:CATX

$2.77 -0.22 (-7.36%)

Closing price 09/10/2026 04:10 PM Eastern

Extended Trading

$2.87 +0.10 (+3.65%)

As of 07:01 AM Eastern

Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective Therapeutics

Market Capitalization: $341.31 million
Consensus Rating: Buy
Consensus Price Target: $11.50 (+315.2% Upside)
Volume: 1.58 million shares
Average Volume: 980,710 shares
Today's Range: $2.75
▼
$3.01

9. Compugen NASDAQ:CGEN

$2.46 -0.02 (-0.81%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$2.46 0.00 (-0.20%)

As of 09/10/2026 07:30 PM Eastern

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. More about Compugen

Market Capitalization: $234.49 million
P/E Ratio: 6.47
Consensus Rating: Buy
Consensus Price Target: $5.00 (+103.3% Upside)
Volume: 206,982 shares
Average Volume: 298,103 shares

10. Stereotaxis NYSEAMERICAN:STXS

$1.30 -0.02 (-1.52%)

Closing price 09/10/2026 04:10 PM Eastern

Extended Trading

$1.37 +0.07 (+5.31%)

As of 07:01 AM Eastern

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. More about Stereotaxis

Market Capitalization: $132.27 million
Consensus Rating: Buy
Consensus Price Target: $3.50 (+169.2% Upside)
Volume: 625,295 shares
Average Volume: 487,377 shares
Today's Range: $1.27
▼
$1.33

11. Equillium NASDAQ:EQ

$2.42 -0.14 (-5.47%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$2.34 -0.08 (-3.31%)

As of 09/10/2026 07:48 PM Eastern

Equillium, Inc, a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. More about Equillium

Market Capitalization: $162.32 million
Consensus Rating: Moderate Buy
Consensus Price Target: $7.57 (+212.9% Upside)
Volume: 397,312 shares
Average Volume: 397,479 shares
Today's Range: $2.41
▼
$2.69

12. Ovid Therapeutics NASDAQ:OVID

$2.63 -0.07 (-2.59%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$2.66 +0.02 (+0.95%)

As of 09/10/2026 07:51 PM Eastern

Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid Therapeutics

Market Capitalization: $527.30 million
Consensus Rating: Moderate Buy
Consensus Price Target: $5.86 (+122.7% Upside)
Volume: 1.40 million shares
Average Volume: 1.44 million shares
Today's Range: $2.61
▼
$2.70

13. Autolus Therapeutics NASDAQ:AUTL

$1.96 -0.07 (-3.45%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$1.98 +0.03 (+1.28%)

As of 07:03 AM Eastern

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. More about Autolus Therapeutics

Market Capitalization: $540.31 million
Consensus Rating: Moderate Buy
Consensus Price Target: $10.00 (+410.2% Upside)
Volume: 1.33 million shares
Average Volume: 2.22 million shares
Today's Range: $1.95
▼
$2.02

14. Compass Therapeutics NASDAQ:CMPX

$2.05 -0.13 (-5.96%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$2.08 +0.03 (+1.46%)

As of 07:01 AM Eastern

Compass Therapeutics, Inc, a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. More about Compass Therapeutics

Market Capitalization: $392.59 million
Consensus Rating: Moderate Buy
Consensus Price Target: $11.77 (+474.1% Upside)
Volume: 2.54 million shares
Average Volume: 2.20 million shares
Today's Range: $2.04
▼
$2.17

15. Nkarta NASDAQ:NKTX

$2.81 -0.10 (-3.44%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$2.88 +0.07 (+2.35%)

As of 07:00 AM Eastern

Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about Nkarta

Market Capitalization: $208.43 million
Consensus Rating: Moderate Buy
Consensus Price Target: $11.20 (+298.6% Upside)
Volume: 559,277 shares
Average Volume: 535,299 shares
Today's Range: $2.76
▼
$2.88

16. Tenaya Therapeutics NASDAQ:TNYA

$0.65 -0.01 (-1.85%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$0.65 +0.00 (+0.34%)

As of 07:02 AM Eastern

Tenaya Therapeutics, Inc, a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. More about Tenaya Therapeutics

Market Capitalization: $148.22 million
Consensus Rating: Moderate Buy
Consensus Price Target: $4.00 (+516.5% Upside)
Volume: 2.27 million shares
Average Volume: 1.68 million shares
Today's Range: $0.64
▼
$0.67

17. NervGen Pharma NASDAQ:NGEN

$2.16 +0.03 (+1.41%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$2.12 -0.04 (-1.62%)

As of 04:00 AM Eastern

NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. More about NervGen Pharma

Market Capitalization: $171.74 million
Consensus Rating: Moderate Buy
Consensus Price Target: $14.00 (+548.1% Upside)
Volume: 313,816 shares
Average Volume: 614,919 shares
Today's Range: $2.07
▼
$2.17

18. Rani Therapeutics NASDAQ:RANI

$0.82 -0.02 (-2.14%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$0.81 -0.01 (-1.34%)

As of 07:03 AM Eastern

Rani Therapeutics Holdings, Inc operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. More about Rani Therapeutics

Market Capitalization: $117.09 million
Consensus Rating: Moderate Buy
Consensus Price Target: $8.75 (+964.5% Upside)
Volume: 185,793 shares
Average Volume: 663,663 shares
Today's Range: $0.82
▼
$0.85

19. AEON Biopharma NASDAQ:AEON

$0.30 +0.07 (+28.92%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$0.31 +0.01 (+2.75%)

As of 07:05 AM Eastern

AEON Biopharma, Inc, a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and posttraumatic stress disorder. More about AEON Biopharma

Market Capitalization: $14.86 million
P/E Ratio: 1.65
Consensus Rating: Moderate Buy
Consensus Price Target: $1.33 (+347.7% Upside)
Volume: 202.08 million shares
Average Volume: 2.20 million shares

20. Tritax Big Box REIT OTCMKTS:TTBXF

$2.06 0.00 (0.00%)

As of 09/9/2026

Tritax Big Box REIT plc (ticker: BBOX) is the largest listed investor in high-quality logistics warehouse assets and controls the largest logistics-focused land platform in the UK. More about Tritax Big Box REIT

Market Capitalization: $5.57 billion
Consensus Rating: Moderate Buy
Average Volume: 42 shares
Today's Range: $2.06
▼
$2.06
50-Day Range: $2.06
▼
$2.43
52-Week Range: $1.70
▼
$2.43

21. Data I/O NASDAQ:DAIO

$2.71 -0.07 (-2.52%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$2.72 +0.02 (+0.55%)

As of 09/10/2026 07:30 PM Eastern

Data I/O Corporation, together with its subsidiaries, engages in the design, manufacture, and sale of programming and security deployment systems and services for electronic device manufacturers in the United States, Europe, and internationally. More about Data I/O

Market Capitalization: $26.12 million
Consensus Rating: Moderate Buy
Consensus Price Target: $5.11 (+88.6% Upside)
Volume: 10,215 shares
Average Volume: 29,909 shares
Today's Range: $2.71
▼
$2.85

22. PMV Pharmaceuticals NASDAQ:PMVP

$1.44 +0.07 (+4.73%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$1.40 -0.04 (-2.85%)

As of 07:00 AM Eastern

PMV Pharmaceuticals, Inc, a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. More about PMV Pharmaceuticals

Market Capitalization: $73.50 million
Consensus Rating: Moderate Buy
Consensus Price Target: $4.33 (+200.9% Upside)
Volume: 673,563 shares
Average Volume: 674,352 shares
Today's Range: $1.34
▼
$1.45

23. High Tide NASDAQ:HITI

$2.56 -0.01 (-0.39%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$2.56 0.00 (0.00%)

As of 07:00 AM Eastern

High Tide Inc engages in the cannabis retail business in Canada, the United States, and internationally. The company operates through Retail and Wholesale segments. More about High Tide

Market Capitalization: $226.10 million
Consensus Rating: Moderate Buy
Consensus Price Target: $5.63 (+119.7% Upside)
Volume: 439,512 shares
Average Volume: 484,161 shares
Today's Range: $2.55
▼
$2.61

24. Caribou Biosciences NASDAQ:CRBU

$1.37 -0.07 (-4.86%)

Closing price 09/10/2026 04:00 PM Eastern

Extended Trading

$1.42 +0.05 (+3.94%)

As of 06:20 AM Eastern

Caribou Biosciences, Inc, a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies in the United States and internationally. More about Caribou Biosciences

Market Capitalization: $154.38 million
Consensus Rating: Moderate Buy
Consensus Price Target: $7.75 (+465.7% Upside)
Volume: 1.26 million shares
Average Volume: 986,053 shares
Today's Range: $1.35
▼
$1.44

25. Standard Lithium NYSEAMERICAN:SLI

$2.27 -0.09 (-3.81%)

As of 09/10/2026 04:10 PM Eastern

Standard Lithium Ltd. explores for, develops, and processes lithium brine properties in the United States. Its flagship project is the Lanxess project with area of approximately 150,000 acres located in southern Arkansas. More about Standard Lithium

Market Capitalization: $581.53 million
Consensus Rating: Moderate Buy
Consensus Price Target: $5.16 (+127.4% Upside)
Volume: 810,145 shares
Average Volume: 1.55 million shares
Today's Range: $2.24
▼
$2.34

Best Stocks Under $3 Right Now

1. Ur Energy NYSEAMERICAN:URG

2. CuriosityStream NASDAQ:CURI

3. Nouveau Monde Graphite NYSE:NMG

4. iBio NASDAQ:IBIO

5. Galiano Gold NYSEAMERICAN:GAU

6. Palisade Bio NASDAQ:PALI

7. Inhibikase Therapeutics NASDAQ:IKT

8. Perspective Therapeutics NYSEAMERICAN:CATX

9. Compugen NASDAQ:CGEN

10. Stereotaxis NYSEAMERICAN:STXS

11. Equillium NASDAQ:EQ

12. Ovid Therapeutics NASDAQ:OVID

13. Autolus Therapeutics NASDAQ:AUTL

14. Compass Therapeutics NASDAQ:CMPX

15. Nkarta NASDAQ:NKTX

16. Tenaya Therapeutics NASDAQ:TNYA

17. NervGen Pharma NASDAQ:NGEN

18. Rani Therapeutics NASDAQ:RANI

19. AEON Biopharma NASDAQ:AEON

20. Tritax Big Box REIT OTCMKTS:TTBXF

21. Data I/O NASDAQ:DAIO

22. PMV Pharmaceuticals NASDAQ:PMVP

23. High Tide NASDAQ:HITI

24. Caribou Biosciences NASDAQ:CRBU

25. Standard Lithium NYSEAMERICAN:SLI

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Best Stocks Under $3 Right Now

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools